Inhibitors of Serine Proteases as Potential Therapeutic Agents:  The Road from Thrombin to Tryptase to Cathepsin G

ADVERTISEMENT RETURN TO ISSUEPerspectiveNEXTADDITION / CORRECTIONThis article has been corrected. View the notice.Inhibitors of Serine Proteases as Potential Therapeutic Agents: The Road from Thrombin to Tryptase to Cathepsin G†Bruce E. MaryanoffView Author Information Drug Discovery, Johnson & Johnson Pharmaceutical Research & Development, Spring House, Pennsylvania 19477-0776 Cite this: J. Med. Chem. 2004, 47, 4, 769–787Publication Date (Web):January 13, 2004Publication History Received1 October 2003Published online13 January 2004Published inissue 1 February 2004https://pubs.acs.org/doi/10.1021/jm030493thttps://doi.org/10.1021/jm030493treview-articleACS PublicationsCopyright © 2004 American Chemical SocietyRequest reuse permissionsArticle Views1337Altmetric-Citations41LEARN ABOUT THESE METRICSArticle Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.Citations are the number of other articles citing this article, calculated by Crossref and updated daily. Find more information about Crossref citation counts.The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on the Altmetric Attention Score and how the score is calculated. Share Add toView InAdd Full Text with ReferenceAdd Description ExportRISCitationCitation and abstractCitation and referencesMore Options Share onFacebookTwitterWechatLinked InRedditEmail Other access optionsGet e-Alertsclose SUBJECTS:Chemical structure,Drug discovery,Inhibition,Inhibitors,Peptides and proteins Get e-Alerts